OpenAlex
PricingAboutJobs
Log inGet started
Work

The state of the art of PROTAC technologies for drug discovery

HTML

Year: 2022
Type: review
Source: European Journal of Medicinal Chemistry
DOI: 10.1016/j.ejmech.2022.114290
Authors: Chao Wang, Cangxin Zheng, Han Wang, Liangren Zhang, Zhenming Liu, Ping Xu
Institutions: Peking University, State Key Laboratory of Natural and Biomimetic Drugs
Language: English

Topic: Protein Degradation and Inhibitors
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: PROTACs, targeted protein degradation, degraders, misfolded protein degradation, RNA degradation, drug discovery, cancer therapy, neurodegenerative diseases, antiviral agents
SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, Peking University, National University's Basic Research Foundation of China, Fundamental Research Funds for the Central Universities, Interdisciplinary Medicine Seed Fund of Peking University
Awards: G6937340764, G8146084917
OpenAlex ID: W4220906618
FWCI: 2.731
Cites: 73
Cited by: 138
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security